+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nitazoxanide"

From
Rhinovirus Infections - Pipeline Review, H2 2020 - Product Thumbnail Image

Rhinovirus Infections - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 57 Pages
  • Global
From
Global and Chinese Nitazoxanide Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Nitazoxanide Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 141 Pages
  • China, Global
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Nitazoxanide is a broad-spectrum antiparasitic and antiviral drug used to treat a variety of infectious diseases. It is a nitrothiazolyl salicylamide derivative and is active against protozoa, helminths, and viruses. It is used to treat infections caused by Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, and other protozoa, as well as infections caused by nematodes and trematodes. It is also used to treat viral infections such as rotavirus, norovirus, and adenovirus. Nitazoxanide is available in tablet, suspension, and film-coated tablet forms. It is generally well tolerated, with the most common side effects being nausea, vomiting, and abdominal pain. Nitazoxanide is marketed by several companies, including Alinia Pharmaceuticals, Inc., Cipla Limited, and Zydus Cadila. Show Less Read more